Stay updated on Neratinib for Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Neratinib for Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Neratinib for Metastatic Prostate Cancer Clinical Trial page
- CheckyesterdayChange DetectedThis updates the ClinicalTrials.gov interface/version indicator shown on the page from one revision to the next, without changing the study record content.SummaryDifference0.1%

- Check8 days agoChange DetectedAdded revision v3.5.2 to the record history and removed revision v3.5.0 from the history. This change affects only revision metadata and does not alter the page content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedAdded Revision v3.5.0 and removed Revision v3.4.3 from the record history.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded revision entry v3.4.3 and removed revision v3.4.2 in the Record History.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision: v3.4.2 was added and v3.4.1 removed, along with removal of a government funding operating-status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check79 days agoChange DetectedAdded a government funding lapse notice indicating the NIH Clinical Center is open, and updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.8%

Stay in the know with updates to Neratinib for Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neratinib for Metastatic Prostate Cancer Clinical Trial page.